Publications (67) Publications auxquelles un chercheur a participé

2020

  1. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  2. A randomized trial comparing transanal irrigation and percutaneous tibial nerve stimulation in the management of low anterior resection syndrome

    Colorectal Disease, Vol. 22, Núm. 3, pp. 303-309

  3. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases

    Aging, Vol. 12, Núm. 11, pp. 10337-10358

  4. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

    Clinical and translational gastroenterology, Vol. 11, Núm. 8, pp. e00218

  5. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)

    Helicobacter, Vol. 25, Núm. 5

  6. CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort

    Molecular Biology Reports, Vol. 47, Núm. 3, pp. 1583-1588

  7. COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 7, pp. 408-413

  8. Capsule endoscopy, a useful tool for the diagnosis of a tapeworm infection

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 112, Núm. 1, pp. 71-72

  9. Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)

    Gastroenterology, Vol. 159, Núm. 2, pp. 781-783

  10. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  11. Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions

    Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3

  12. Clinical value of CT-P13 trough levels, an infliximab biosimilar, in the management of inflammatory bowel disease

    Medicina Clinica, Vol. 154, Núm. 12, pp. 475-480

  13. Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility

    Journal of Medical Genetics, Vol. 57, Núm. 10, pp. 677-682

  14. Colorectal cancer survival in 50-to 69-year-olds after introducing the faecal immunochemical test

    Cancers, Vol. 12, Núm. 9, pp. 1-14

  15. Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 89-98

  16. Comparative effects of pterostilbene and its parent compound resveratrol on oxidative stress and inflammation in steatohepatitis induced by high-fat high-fructose feeding

    Antioxidants, Vol. 9, Núm. 11, pp. 1-19

  17. Development of a new risk score for invasive cancer in branch-duct intraductal papillary mucinous neoplasms according to morphological characterization by EUS

    Endoscopic Ultrasound, Vol. 9, Núm. 3, pp. 193-199

  18. Diagnosis and natural history of preclinical and early inflammatory bowel disease

    Annals of Gastroenterology, Vol. 33, Núm. 5, pp. 443-452

  19. Early microscopic findings in preclinical inflammatory bowel disease

    Digestive and Liver Disease, Vol. 52, Núm. 12, pp. 1467-1472

  20. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066